Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
functional residual capacity | lung gas volume at the end of a passive expiration | The pulmonary study includes functional residual capacity measured by plethysmography. | Objective | Pulmonary function, ventilation and oxygen delivery |
fundal height | distance from the pubic symphysis to the top of the pregnant uterus | The measured fundal height is 28 cm. | Objective | Abdomen, pelvis and genitourinary examination |
gait cadence | number of steps taken per minute | Gait cadence was measured at the usual walking speed. | Objective | Gait, transfers and functional measurements |
gait freezing | brief inability to initiate or continue stepping | Gait freezing occurred while turning into the narrow hallway. | Objective | Gait, transfers and functional measurements |
gingival recession | gum margin lies farther toward the root, exposing the root surface | Gingival recession was measured at the buccal aspect of the lower incisor. | Objective | Dentition, gingiva and oral examination |
girth | circumference of a body region | Left calf girth is 3 cm greater at the same landmark. | Objective | Fluid status, bedside devices and measured observations |
glenohumeral abduction | moving the arm sideways at the shoulder joint | Glenohumeral abduction was measured with the scapula stabilized. | Objective | Regional movement and strength examination |
glucose management indicator | estimate derived from mean sensor glucose using the GMI equation | The glucose management indicator was recorded separately from measured hemoglobin A1c. | Objective | Glucose monitoring, endocrine testing and urine studies |
Heavy proteinuria | Large amount of protein lost in the urine | The report documents heavy proteinuria on quantitative urine protein measurement. | Objective | Urinary and reproductive findings |
Heberden nodes | bony enlargements at the distal interphalangeal joints | The examination notes Heberden nodes at several fingers. | Objective | Muscle, joint fluid and inflammatory measurements |
hepatic clearance | removal of a drug by the liver | The review considers changes in hepatic clearance since the prior measurement. | Assessment | Drug levels - exposure and pharmacokinetics |
hip hiking | raising one side of the pelvis to advance the limb | Hip hiking helped clear the right foot during swing. | Objective | Gait, transfers and functional measurements |
hydration | body water status in context | The examination of hydration included oral mucosa and measured weight. | Objective | Fluid status, bedside devices and measured observations |
hyperosmolar state | increased concentration of dissolved particles in body fluid, interpreted with effective solutes specified | Hyperosmolar state was characterized with glucose, sodium and measured osmolality. | Assessment | Acid-base and electrolyte interpretation |
Hyperparathyroidism | Excess parathyroid hormone production for the clinical context | The assessment includes hyperparathyroidism with paired calcium and parathyroid hormone measurements. | Assessment | Inflammatory, immune and endocrine assessment |
hypochloremia | low serum chloride | Repeat measurement confirms hypochloremia. | Objective | Electrolytes, acid-base and metabolic testing |
hypoglycemia awareness | ability to perceive warning symptoms as glucose falls | Hypoglycemia awareness was assessed from recent episodes and glucose measurements. | Objective | Glucose monitoring, endocrine testing and urine studies |
hypoperfusion | inadequate blood delivery to tissue | The cool extremities and measured pressures raise concern for hypoperfusion. | Assessment | Volume, organ function and illness severity |
hypotensive | blood pressure is low | Hypotensive on repeat measurement at 82/48 mm Hg. | Objective | Vital signs and bedside observations |
| test that uses antibody recognition | The outside concentration was measured by immunoassay. | Objective | Drug levels - analyte, specimen and reporting | |
inactive metabolite | breakdown product without the relevant pharmacologic activity | The laboratory identified the measured compound as an inactive metabolite. | Assessment | Medication response, exposure and reconciliation |
individual parameter estimate | model-derived value for a specific person's pharmacokinetic parameter | The individual parameter estimate was updated after the second timed measurement. | Assessment | Drug concentrations, exposure and assay interpretation |
| nonvesicant infusion fluid has entered surrounding tissue | The nursing assessment documents peripheral IV infiltration. | Objective | Fluid status, bedside devices and measured observations | |
infiltration site | area where infused solution has entered nearby tissue | The infiltration site was measured and compared with the opposite limb. | Objective | Vascular access and infusion observations |
initial contact | first point of foot contact during a step | Initial contact occurred at the forefoot on the left. | Objective | Gait, transfers and functional measurements |